~~<i id='64595F900C'><strike id='64595F900C'><tt id='64595F900C'><pre id='64595F900C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：Wikipedia 2025-09-06 04:42:24 - browse：353

J.P. Morgan office building at night -- JPM health business coverage from STAT — Adobe

SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.

Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

Their message? We’re still here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why more medical students aren't specializing in primary care

focus

hotspot

focus

leisure time

explore

leisure time

AdobeTheU.S.isrunninglowonprimarycarephysicians,withanestimatedshortageofbetween17,800and48,000predi

WSS

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Why more medical students aren't specializing in primary care

2024 GOP presidential candidates spar over abortion in debate

How Long Island became the ‘eugenics capital of the world’

Study finds new variant for Parkinson’s in African populations

The woman behind the Dana Farber

focus

hotspot

focus

Jerome Adams on the need for new antivirals for Covid

In science, is the line between industry and academia shifting?

At least 13 dead in Texas as scorching temps continue

What PEPFAR has meant on the ground in Ukraine

Peter Hotez and the public health issue of online harassment

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Malaria cases in Florida and Texas: Here’s what you need to know

FDA panel gives mixed vote on blood pressure devices

Cancer drug shortages should be causing more outrage

How a symptom of dementia informs our understanding of creativity

hotspot

CMS should re

FDA needs staff influx to meet gene therapy needs, Marks says

Study finds new variant for Parkinson’s in African populations

What PEPFAR has meant on the ground in Ukraine

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Feds fine Medicare Advantage plans for overcharging members

focus

leisure time

explore

leisure time